Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 346

The DOI matches its Crossref record.

Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice

MALLE, E., DE BEER, F. C. · 1996 · European Journal of Clinical Investigation

Abstract

Serum amyloid A (SAA) proteins comprise a family of apolipoproteins synthesized in response to cytokines released by activated monocytes/macrophages. Acute‐phase protein concentrations have been advocated as objective biochemical indices of disease activity in a number of different inflammatory processes. Clinical studies in large groups of patients with a variety of disorders confirmed the rapid production and exceptionally wide dynamic range of the SAA response. It is as sensitive a marker for the acute‐phase as C‐reactive protein (CRP). Recent studies indicate that SAA is the most sensitive non‐invasive biochemical marker for allograft rejection. Further studies comparing the measurement of SAA to CRP could reveal other indications for its specific use. These studies are now more feasible given newer assays to measure this acute‐phase reactant. Observations that the acute‐phase response is tightly coupled to lipoprotein abnormalities and the fact that acute‐SAA proteins are mainly associated with plasma lipoproteins of the high density range suggested a possible role of this apolipoprotein (apo SAA) in the development of atherosclerosis. The expression of SAA mRNA in human atherosclerotic lesions and the induction of acute‐phase SAA by oxidized low‐density lipoproteins strengthen the hypothesis that SAA might play a role in vascular injury and atherogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2362.1996.159291.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 346

Metadata

Authors
MALLE, E., & DE BEER, F. C.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
1996-06
Volume
26
Issue
6
Pages
427-435
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2072113749
Cited by
346
References
0
FWCI
3.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice. https://app.cochat.ai/papers/10.1046/j.1365-2362.1996.159291.x
The paper
MALLE, E., & DE BEER, F. C. (1996). Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.1996.159291.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.